CHELSEA JOHNSON: Open Payments
NPI 1770164105 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 47 payments from 16 companies in 2025. Trend: 2023 $1,112 · 2024 $1,104 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $119 |
| Novo Nordisk Inc | 6 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $109 |
| Lilly USA, LLC | 6 | $106 |
| Lundbeck LLC | 4 | $88 |
| ABBVIE INC. | 3 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Astellas Pharma US Inc | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
Products named: REXULTI, JARDIANCE, MOUNJARO, Ozempic, ELIQUIS, VRAYLAR, NURTEC ODT, Wegovy.
Industry payments across NC — which companies pay providers there.
